BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31274043)

  • 1. The potential impact of chronic obstructive pulmonary disease in lung cancer screening: implications for the screening clinic.
    Young RP; Hopkins R
    Expert Rev Respir Med; 2019 Aug; 13(8):699-707. PubMed ID: 31274043
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of two lung cancer screening scores among patients with chronic obstructive pulmonary disease: A community study.
    Gagnat AA; Gulsvik A; Bakke P; Gjerdevik M
    Clin Respir J; 2019 Feb; 13(2):114-119. PubMed ID: 30597746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Personalizing annual lung cancer screening for patients with chronic obstructive pulmonary disease: A decision analysis.
    Lowry KP; Gazelle GS; Gilmore ME; Johanson C; Munshi V; Choi SE; Tramontano AC; Kong CY; McMahon PM
    Cancer; 2015 May; 121(10):1556-62. PubMed ID: 25652107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Airflow Limitation and Histology Shift in the National Lung Screening Trial. The NLST-ACRIN Cohort Substudy.
    Young RP; Duan F; Chiles C; Hopkins RJ; Gamble GD; Greco EM; Gatsonis C; Aberle D
    Am J Respir Crit Care Med; 2015 Nov; 192(9):1060-7. PubMed ID: 26199983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of chronic obstructive pulmonary disease and smoking status with bone density and vertebral fractures in male lung cancer screening participants.
    de Jong WU; de Jong PA; Vliegenthart R; Isgum I; Lammers JW; Oudkerk M; van der Aalst C; de Koning HJ; Mohamed Hoesein FA
    J Bone Miner Res; 2014 Oct; 29(10):2224-9. PubMed ID: 24715549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of chronic obstructive pulmonary disease in community-based annual lung cancer screening: Chiba Chronic Obstructive Pulmonary Disease Lung Cancer Screening Study Group.
    Sekine Y; Fujisawa T; Suzuki K; Tsutatani S; Kubota K; Ikegami H; Isobe Y; Nakamura M; Takiguchi Y; Tatsumi K
    Respirology; 2014 Jan; 19(1):98-104. PubMed ID: 24033868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung Cancer Screening in Patients with COPD-A Case Report.
    Amirahmadi R; Kumar AJ; Cowan M; Deepak J
    Medicina (Kaunas); 2019 Jul; 55(7):. PubMed ID: 31336732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improving selection criteria for lung cancer screening. The potential role of emphysema.
    Sanchez-Salcedo P; Wilson DO; de-Torres JP; Weissfeld JL; Berto J; Campo A; Alcaide AB; Pueyo J; Bastarrika G; Seijo LM; Pajares MJ; Pio R; Montuenga LM; Zulueta JJ
    Am J Respir Crit Care Med; 2015 Apr; 191(8):924-31. PubMed ID: 25668622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced Expiratory Flow Rate among Heavy Smokers Increases Lung Cancer Risk. Results from the National Lung Screening Trial-American College of Radiology Imaging Network Cohort.
    Hopkins RJ; Duan F; Chiles C; Greco EM; Gamble GD; Aberle D; Young RP
    Ann Am Thorac Soc; 2017 Mar; 14(3):392-402. PubMed ID: 28076701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing the Generalizability of the National Lung Screening Trial: Comparison of Patients with Stage 1 Disease.
    Tanner NT; Dai L; Bade BC; Gebregziabher M; Silvestri GA
    Am J Respir Crit Care Med; 2017 Sep; 196(5):602-608. PubMed ID: 28722466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of chronic obstructive pulmonary disease in lung cancer screening computed tomographic scans.
    Mets OM; Buckens CF; Zanen P; Isgum I; van Ginneken B; Prokop M; Gietema HA; Lammers JW; Vliegenthart R; Oudkerk M; van Klaveren RJ; de Koning HJ; Mali WP; de Jong PA
    JAMA; 2011 Oct; 306(16):1775-81. PubMed ID: 22028353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-Level Trajectories and Outcomes After Low-Dose CT Screening in the National Lung Screening Trial.
    Iaccarino JM; Silvestri GA; Wiener RS
    Chest; 2019 Nov; 156(5):965-971. PubMed ID: 31283920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Airflow limitation and mortality during cancer screening in the National Lung Screening Trial: why quantifying airflow limitation matters.
    Young RP; Ward RC; Scott RJ; Gamble GD; Silvestri G
    Thorax; 2023 Jul; 78(7):690-697. PubMed ID: 36456179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung cancer in patients with chronic obstructive pulmonary disease. Development and validation of the COPD Lung Cancer Screening Score.
    de-Torres JP; Wilson DO; Sanchez-Salcedo P; Weissfeld JL; Berto J; Campo A; Alcaide AB; García-Granero M; Celli BR; Zulueta JJ
    Am J Respir Crit Care Med; 2015 Feb; 191(3):285-91. PubMed ID: 25522175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the impact of screening with low-dose CT on lung cancer mortality in mild to moderate COPD patients: a pilot study.
    de-Torres JP; Casanova C; Marín JM; Zagaceta J; Alcaide AB; Seijo LM; Campo A; Carrizo S; Montes U; Cordoba-Lanus E; Baz-Dávila R; Aguirre-Jaime A; Celli BR; Zulueta JJ
    Respir Med; 2013 May; 107(5):702-7. PubMed ID: 23465176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Early detection of lung cancer using computed tomography among patients with chronic obstructive pulmonary disease].
    Saldías P F; Díaz P JC; Rain M C; Illanes C P; Díaz T R; Díaz P O
    Rev Med Chil; 2016 Feb; 144(2):202-10. PubMed ID: 27092675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.
    Tammemagi MC; Schmidt H; Martel S; McWilliams A; Goffin JR; Johnston MR; Nicholas G; Tremblay A; Bhatia R; Liu G; Soghrati K; Yasufuku K; Hwang DM; Laberge F; Gingras M; Pasian S; Couture C; Mayo JR; Nasute Fauerbach PV; Atkar-Khattra S; Peacock SJ; Cressman S; Ionescu D; English JC; Finley RJ; Yee J; Puksa S; Stewart L; Tsai S; Haider E; Boylan C; Cutz JC; Manos D; Xu Z; Goss GD; Seely JM; Amjadi K; Sekhon HS; Burrowes P; MacEachern P; Urbanski S; Sin DD; Tan WC; Leighl NB; Shepherd FA; Evans WK; Tsao MS; Lam S;
    Lancet Oncol; 2017 Nov; 18(11):1523-1531. PubMed ID: 29055736
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Airflow limitation and survival after surgery for non-small cell lung cancer: Results from a systematic review and lung cancer screening trial (NLST-ACRIN sub-study).
    Hopkins RJ; Ko J; Gamble GD; Young RP
    Lung Cancer; 2019 Sep; 135():80-87. PubMed ID: 31447006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship Between Emphysema Severity and the Location of Lung Cancer in Patients With Chronic Obstructive Lung Disease.
    Lim J; Shin KM; Lee K; Lim JK; Kim HJ; Cho SH; Cha SI
    AJR Am J Roentgenol; 2015 Sep; 205(3):540-5. PubMed ID: 26295639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of the cancer risk management model lung cancer screening module.
    Flanagan WM; Evans WK; Fitzgerald NR; Goffin JR; Miller AB; Wolfson MC
    Health Rep; 2015 May; 26(5):11-8. PubMed ID: 25993046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.